Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
BALCHEM CORP (BCPC)
|
Add to portfolio |
|
|
|
| Price: |
$167.02
| | Metrics |
| OS: |
32.2
|
M
| |
11
|
% ROE
|
| Market cap: |
$5.37
|
B
| |
|
|
|
Net debt:
|
$339
|
M
| |
1.8
|
x Debt/EBITDA
|
|
EV:
|
$5.71
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$193
|
M
| |
29.6
|
x EV/EBITDA
|
|
EBIT
|
$145
|
M
| |
39.5
|
x EV/EBIT
|
| EPS |
$3.34
| |
50.0
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 942.4 | 799.0 | 703.6 | 643.7 | 643.7 | 594.8 | 553.2 | 552.5 |
| Revenue growth | 17.9% | 13.6% | 9.3% | 0.0% | 8.2% | 7.5% | 0.1% | 2.1% |
| Cost of goods sold | 661.9 | 555.8 | 479.7 | 432.3 | 439.4 | 405.8 | 372.3 | 384.4 |
| Gross profit | 280.5 | 243.2 | 223.9 | 211.4 | 204.3 | 189.0 | 180.9 | 168.1 |
| Gross margin | 29.8% | 30.4% | 31.8% | 32.8% | 31.7% | 31.8% | 32.7% | 30.4% |
| Sales and marketing | 67.4 | 60.4 | 58.6 | 60.9 | 57.2 | 54.7 | 55.2 | 46.3 |
| Research and development | 12.2 | 13.5 | 10.3 | 11.4 | 11.6 | 9.3 | 7.3 | 6.0 |
| General and administrative | 55.7 | 41.7 | 43.8 | 36.5 | 28.3 | 28.1 | 27.5 | 21.9 |
| EBITA | 172.5 | 152.6 | 139.0 | 128.3 | 132.1 | 123.7 | 120.6 | 120.4 |
| EBITA margin | 18.3% | 19.1% | 19.7% | 19.9% | 20.5% | 20.8% | 21.8% | 21.8% |
| Amortization of intangibles | 27.3 | 25.1 | 27.8 | 25.8 | 25.0 | 26.8 | 29.8 | 26.5 |
| EBIT | 145.2 | 127.5 | 111.1 | 102.6 | 107.1 | 96.9 | 90.8 | 94.0 |
| EBIT margin | 15.4% | 16.0% | 15.8% | 15.9% | 16.6% | 16.3% | 16.4% | 17.0% |
| Pre-tax income | 133.7 | 125.2 | 106.4 | 96.5 | 99.0 | 88.5 | 82.9 | 87.1 |
| Income taxes | 28.4 | 29.1 | 21.8 | 16.8 | 20.5 | -1.6 | 27.0 | 27.3 |
| Tax rate | 21.2% | 23.3% | 20.5% | 17.4% | 20.7% | | 32.5% | 31.4% |
| Net income | 105.4 | 96.1 | 84.6 | 79.7 | 78.6 | 90.1 | 56.0 | 59.7 |
| Net margin | 11.2% | 12.0% | 12.0% | 12.4% | 12.2% | 15.1% | 10.1% | 10.8% |
| |
| Diluted EPS | $3.25 | $2.94 | $2.60 | $2.45 | $2.42 | $2.79 | $1.75 | $1.89 |
| Shares outstanding (diluted) | 32.4 | 32.7 | 32.5 | 32.5 | 32.4 | 32.2 | 31.9 | 31.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|